Wells Fargo & Company Medical Devices

Wells Fargo & Company

$433 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BVS Bioventus Inc.	$642M	$236,000 0.0% of portfolio	22,494	Q4 2024 Added 32.05%
ESTA Establishment Labs Holdings Inc.	$876M	$233,000 0.0% of portfolio	5,068	Q4 2024 Reduced 3.6%
KIDS Orthopediatrics Corp	$564M	$228,000 0.0% of portfolio	9,853	Q4 2024 Added 31.11%
TMCI Treace Medical Concepts, Inc.	$558M	$184,000 0.0% of portfolio	24,796	Q4 2024 Added 45.63%
RCEL Avita Medical, Inc.	$263M	$178,000 0.0% of portfolio	13,941	Q4 2024 Added 41.23%
CERS Cerus Corp	$328M	$158,000 0.0% of portfolio	103,032	Q4 2024 Added 9.58%
VMD Viemed Healthcare, Inc.	$299M	$128,000 0.0% of portfolio	16,024	Q4 2024 Added 51.7%
INGN Inogen Inc	$243M	$127,000 0.0% of portfolio	13,917	Q4 2024 Added 27.84%
LUNG Pulmonx Corp	$260M	$125,000 0.0% of portfolio	18,418	Q4 2024 Added 48.71%
ANIK Anika Therapeutics, Inc.	$261M	$122,000 0.0% of portfolio	7,421	Q4 2024 Added 31.07%
CVRX Cv Rx, Inc.	$303M	$112,000 0.0% of portfolio	8,894	Q4 2024 Added 86.11%
CUTR Cutera Inc	$9.4M	$81,000 0.0% of portfolio	233,717	Q4 2024 Added 8.61%
NVRO Nevro Corp	$202M	$80,000 0.0% of portfolio	21,595	Q4 2024 Added 29.9%
ICAD Icad Inc	$84.1M	$72,000 0.0% of portfolio	39,542	Q4 2024 Added 51.27%
NPCE Neuro Pace Inc	$276M	$72,000 0.0% of portfolio	6,483	Q4 2024 Added 54.21%
QIPT Quipt Home Medical Corp.	$105M	$72,000 0.0% of portfolio	23,851	Q4 2024 Added 30.86%
SGHT Sight Sciences, Inc.	$131M	$60,000 0.0% of portfolio	16,600	Q4 2024 Added 53.43%
BFLY Butterfly Network, Inc.	$826M	$46,000 0.0% of portfolio	14,839	Q4 2024 Added 15.15%
PROF Profound Medical Corp.	$131M	$35,000 0.0% of portfolio	4,784	Q1 2024 Added 41.92%
MASS 908 Devices Inc.	$87.8M	$30,000 0.0% of portfolio	13,708	Q4 2024 Added 16.78%
ELMD Electromed, Inc.	$271M	$20,000 0.0% of portfolio	700	Q4 2024 Added 133.33%
DCTH Delcath Systems, Inc.	$140M	$17,000 0.0% of portfolio	1,503	Q4 2024 Reduced 38.73%
SENS Senseonics Holdings, Inc.	$577M	$16,000 0.0% of portfolio	30,977	Q3 2024 Reduced 67.84%
EDAP Edap Tms Sa	$103M	$7,000 0.0% of portfolio	3,500	Q1 2020 New
NVNO En V Veno Medical Corp	$33.7M	$5,000 0.0% of portfolio	2,000	Q2 2024 Reduced 4.53%
HYPR Hyperfine, Inc.	$66.6M	$2,000 0.0% of portfolio	2,581	Q4 2024 New
IINN Inspira Technologies Oxy B.H.N. LTD	$9.97M	$2,000 0.0% of portfolio	2,050	Q4 2024 New
CLPT Clear Point Neuro, Inc.	$449M	$1,000 0.0% of portfolio	69	Q3 2024 Added 176.0%
LNSR Lensar, Inc.	$116M	$1,000 0.0% of portfolio	189	Q2 2024 Reduced 27.59%
LUCD Lucid Diagnostics Inc.	$56.3M	$1,000 0.0% of portfolio	2,300	Q4 2024 Reduced 6.62%
NXL Nexalin Technology, Inc.	$24.1M	$1,000 0.0% of portfolio	600	Q4 2024 New
BIO-B Bio Rad Laboratories, Inc.	$11.2B	$0 0.0% of portfolio	-	Q2 2023 Added 203.57%
BWAY Brainsway Ltd.	$187M	$0 0.0% of portfolio	70	Q4 2024 Reduced 97.42%
CODX Co Diagnostics, Inc.	$23.3M	$0 0.0% of portfolio	1,175	Q3 2024 Added 327.27%
CTSO Cytosorbents Corp	$56.7M	$0 0.0% of portfolio	250	Q3 2024 Reduced 44.81%
AZYO Aziyo Biologics, Inc.	$13.5M	$0 0.0% of portfolio	500	Q4 2024 Reduced 95.91%
FONR Fonar Corp	$107M	$0 0.0% of portfolio	13	Q4 2024 Reduced 7.14%
NMTC Neuroone Medical Technologies Corp	$19.5M	$0 0.0% of portfolio	333	Q3 2024 New
XTNT Xtant Medical Holdings, Inc.	$64.9M	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.73%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.